Clinical trial
A Prospective, Multicenter, Single-arm, Observational Study to Evaluate the Safety and Effectiveness of Vedolizumab in Real-World Clinical Practice in China
NCT04872491 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single-arm, Observational Study to Evaluate the Safety and Effectiveness of Vedolizumab in Real-World Clinical Practice in China
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 22, 2021
- Completion date
- July 17, 2024
- Enrollment
- 500 (actual)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.